|Articles|October 13, 2004
Contrast business prepares for shake-up
Advertisement
Bracco has invested in Chinese facilities to produce and ship contrast media. The investments are being made through a joint venture with Shanghai-based Sine Pharmaceutical. The Bracco-Sine production plant opened in June in Shanghai's high-tech district. It will focus on the final cycle in contrast media production. Chinese workers will formulate drug solutions from basic ingredients sent from Italy, then prepare, seal, and sterilize individual doses.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Advertisement
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Assessing the Potential Impact in Radiology for GE HealthCare’s Acquisition of Intelerad
2
Diagnostic Imaging's Weekly Scan: November 30 — December 6
3
RSNA: CCTA Study Reveals Link Between Common Air Pollutants and Coronary Artery Stenosis
4
The Potential of Mammography Image-Based AI Models for Assessing Risk: An Interview with Constance Lehman, MD
5
























